SFSIG
BIVV

San Francisco Sentry Investment Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

San Francisco Sentry Investment Group’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-14
Closed -$1K – 955
2017
Q4 		$1K Hold
14
– – ﹤0.01% 898
2017
Q3 		$1K Hold
14
– – ﹤0.01% 911
2017
Q2 		$1K Buy
+14
New +$797 ﹤0.01% 747

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

San Francisco Sentry Investment Group's BIVV Position: Q1 2018 in Review

San Francisco Sentry Investment Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 14 shares — an estimated $1K sold.

San Francisco Sentry Investment Group first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $1K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • San Francisco Sentry Investment Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • San Francisco Sentry Investment Group sold 14 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1K.
  • San Francisco Sentry Investment Group first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
  • San Francisco Sentry Investment Group's Bioverativ Inc. Common Stock position peaked at $1K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on San Francisco Sentry Investment Group's 13F filing for Q1 2018, filed 4 May 2018.